Regulatory Oversight of Human Pathogens and Toxins in Canada
Overview
Public Health
Authors
Affiliations
From 1994 to 2009, federal oversight of human pathogens and toxins was limited to facilities importing human pathogens and toxins into Canada under the (HPIR). This narrow focus of authority restricted the Government of Canada's ability to regulate and monitor a full range of activities, including those involving human pathogens and toxins acquired from domestic sources. In 2009, the (the Act) received Royal Assent to establish a national safety and security regime and expand oversight through a national, standardized process to verify safe and secure use of human pathogens and toxins in Canada. The Act and the (the Regulations), in full force since December 1, 2015, provides legislative and statutory requirements for the comprehensive oversight of the control of human pathogens and toxins in Canada. Expanded regulation and monitoring program activities aim to reduce the risks posed by human pathogens and toxins and strengthen biosafety management systems that serve to protect the health of Canadians.
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.
Bienek A, Heisz M, Su M Can Commun Dis Rep. 2018; 43(11):228-235.
PMID: 29770052 PMC: 5764741. DOI: 10.14745/ccdr.v43i11a04.
Federal public health strategies to minimize the importation of communicable diseases into Canada.
Bhatia N, Sarwal S, Robinson H, Geduld J, Huneault F, Schreiner H Can Commun Dis Rep. 2018; 41(Suppl 6):3-8.
PMID: 29769971 PMC: 5868714. DOI: 10.14745/ccdr.v41is6a01.